The incidence of exacerbations in the disease course was investigated in 110 patients with systemic lupus erythematosus (SLE) who were studied prospectively at our institute for lupus research. At the time of disease onset and diagnosis the male patients were much older than the female patients (about 10 years); exacerbation frequency during follow up was increased in the male patients. The follow up data showed that if a patient with SLE was prone to develop an exacerbation this mostly took place within the first five years of follow up. It could be calculated that after fulfilling the American Rheumatism Association criteria only 56% (62/110) of the patients developed a subsequent exacerbation. Features at the time of diagnosis, distinguishing those patients who developed a subsequent exacerbation from those who did not, were haemolytic anaemia, the presence of anti-Sm antibodies, and a falsely positive serological test for syphylis. At the time of diagnosis, however, the prevalences of these features were low; for haemolytic anaemia, anti-Sm antibodies, and a falsely positive serological test for syphilis they amounted to 40%, 5%, and 12% respectively.
the characteristic skin and joint manifestations, which mostly form the initial complaints of the patient, are not present.
Many reports have focused on questions related to treatment or prognosis of patients who had developed renal, cardiopulmonary, and other organ manifestations of the disease.97 Incidence frequencies of the various disease features have always been described retrospectively or by transversal studies, or both, of a given number of patients with SLE. It must be emphasised that the disease course is characterized by fluctuations in activity. Disease activity may be profound at some times but may be followed by periods of relative absence of symptoms. It is also important to realise that SLE may have long periods of remission; some patients may live for 10 to 15 tears, completely free from active symptoms.8Jl
The studies we started in 1970 (see preceding 455
paper and refs [12] [13] [14] now permit a prospective evaluation of the disease course of a large group of patients. The aim of the present study was to evaluate which patients with SLE will develop an exacerbation and with what frequency, and whether factors can be identified to predict the development of an exacerbation. Furthermore, the influence of factors, like sex, age of onset, age of diagnosis, and clinical signs at onset, on the disease course have been studied.
Patients and methods

PATIENTS
All patients fulfilling the preliminary ARA criteria for SLE,15 and who were seen and followed up by either AJGS or WB at our lupus outpatient clinics since 1970, took part in the study. The patients were first seen at our department for diagnostic reasons. At that time the diagnosis SLE was either confirmed or rejected. If patients later developed SLE they were then also incorporated in this study. One hundred and ten patients were selected for evaluation; they have been followed up until now at our outpatient clinic for lupus research. Demographic features of these 110 patients have been given in the preceding paper.
DISEASE ACTIVITY
Disease activity can be divided into minor and major symptoms,12 13 (14) 47 (14) *At the moment of diagnosis-that is, fulfilling more than four of the American Rheumatism Association criteria. (Table 3) . Figure 1 shows the time intervals between the moment of diagnosis and an exacerbation for all patients developing one or more exacerbations. Figure 2 summarises cumulatively the results of Table 3 and Fig. 1 From these data it is clear that if a patient with SLE is prone to develop an exacerbation this will take place within the first five years of follow up. The first exacerbations mostly took place three years after the initial diagnosis. Conversely, it can experienced their second exacerbation within three also be stated that if a patient has not developed an years of the first. exacerbation after five years of follow up the chance of developing an exacerbation will be very small. 
